Self-control and co-responsibility: a step forward in stakeholder involvement in control and inspection processes
Self-control and co-responsibility are the result of a new control policy implemented by the FAMHP Directorate General Inspection. This policy is adapted to the different stakeholders according to their sector, with the common goal of making these players more responsible and involved in optimising the inspections and controls carried out by the FAMHP. The inspection […]
Building the future: positive results for the FAMHP during BEMA improvement exercise
The FAMHP participated in the improvement exercise ‘Benchmarking of European Medicines Agencies’ (BEMA) in 2023. This improvement exercise gives the agency an opportunity to evaluate performance and then further optimise it. The FAMHP successfully completed the exercise and achieved positive results; also, the average score per area increased compared to the previous edition in 2016. […]
How the ‘Meet the Expert’ project encourages collaboration within the FAMHP
Training and continuous development are crucial within the FAMHP. In a world that is constantly evolving both technologically and innovatively, it goes without saying that we cannot be left behind. The Personnel and Organisation (P&O) division therefore launched the ‘Meet the expert’ project in which employees are given the opportunity to follow colleagues for one […]
Hugues Malonne: looking back on his first months as Chief Executive Officer
In September 2023, Hugues Malonne took over as head of the Federal Agency for Medicines and Health Products. Having previously held the position of Director General of DG POST authorisation and then DG PRE authorisation, Hugues was well aware of the amount of work that lay ahead. This annual report is an opportunity to find […]
Out with paper narcotic drugs order forms, welcome narcoreg.be
In Belgium, any delivery or receipt of narcotic drugs and psychotropic substances must be registered with the FAMHP. This used to be done using paper narcotic drugs order forms. Since September 2023, Narcoreg has been put in place, an online application that digitalises the entire process with time savings for pharmacists, suppliers and the FAMHP. […]
PharmaInfo: an innovative website for citizens and patients with clear and reliable information about medicines and health products
In December 2023, the FAMHP launched www.PharmaInfo.be. A website tailored to citizens and patients had long been an idea of the FAMHP. As part of a multi-year patient information plan, this project became much more concrete, and thanks to the explicit support of the Minister for Health, it gained momentum. In the autumn of 2022, […]
From antibiotic dose fractionation to phage therapy: developments in the fight against antimicrobial resistance
Antimicrobial resistance (AMR) has been a major challenge for global human and animal health for several years. Therefore, the FAMHP is committed to fighting AMR with a number of concrete actions. The aim is to reduce and optimise the use of antimicrobial agents, particularly antibiotics, to prevent the development and spread of resistant germs. In […]
From meticulous analyses to concrete actions: how the FAMHP is addressing medicine shortages
Unavailability of medicines is a problem that affects many patients every year. This issue is therefore high on the agenda both at the national and international/European levels.. In recent years, the FAMHP has invested in a multifaceted approach to unavailable medicines with both practical actions on the ground and legislative initiatives. At the FAMHP, every […]
Xavier De Cuyper looks back on his years at the Federal Agency for Medicines and Health Products (FAMHP)
Xavier De Cuyper led the FAMHP from 1 May 2007. He was the agency’s first chief executive officer, coming on board at its inception. In 2022, he reached the age limit for holding a mandate within the federal government, but his term was extended to ensure the FAMHP kept running smoothly, pending the appointment of […]
